Effect of Oral Activated Charcoal on Parasite Clearance Rates in Response to Intravenous Artesunate in Malian Children With Uncomplicated Plasmodium Falciparum Malaria

Trial Profile

Effect of Oral Activated Charcoal on Parasite Clearance Rates in Response to Intravenous Artesunate in Malian Children With Uncomplicated Plasmodium Falciparum Malaria

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2015

At a glance

  • Drugs Artesunate (Primary) ; Amodiaquine; Charcoal
  • Indications Malaria
  • Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 30 Jul 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 07 Apr 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Mar 2015 to 1 Mar 2016.
    • 07 Apr 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top